Dr. Danae Delivanis on Pembrolizumab and Nivolumab in Metastatic Melanoma
Danae Delivanis, MD, endocrinologist, Mayo Clinic, on the use of pembrolizumab and nivolumab in the treatment of metastatic melanoma.
Dr. Delivanis on Pembrolizumab-Induced Thyroiditis
Danae Delivanis, MD, Division of Endocrinology, Diabetes, Metabolism, and Nutrition at Mayo Clinic, discusses pembrolizumab-induced thyroiditis in patients with cancer.